Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
details to the methods and tables with raw data are missing

Data source

Reference
Reference Type:
publication
Title:
Toxicity of disodium sebacate
Author:
Greco A.V., Mingrone G., Mastrimattei A. E., Finotti E., Castagneto M.
Year:
1990
Bibliographic source:
DRUGS EXPTL. CLIN. RES. XVI (10) 531-536

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium sebacate
EC Number:
241-300-3
EC Name:
Disodium sebacate
Cas Number:
17265-14-4
Molecular formula:
C10H18O4.2Na
IUPAC Name:
disodium sebacate
Test material form:
solid

Test animals

Species:
rabbit
Strain:
New Zealand White
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: adult
- Housing: separate
- Diet: ad libitum
- Water: ad libitum

Administration / exposure

Route of administration:
oral: feed
Vehicle:
other: pellet diet
Details on exposure:
DIET PREPARATION
- Mixing appropriate amounts with: pellet diet

VEHICLE
- Concentration in vehicle:
Details on mating procedure:
- Impregnation procedure: cohoused
- If cohoused:
- ♂/♀ ratio per cage: 1/20
- Length of cohabitation: 10 days
Duration of treatment / exposure:
Group 1: 10 animals: day 1 to 25 of pregnancy,
Group 2: 10 animals: day 1 to 25 of pregnancy plus 3 months including suckling period
Frequency of treatment:
continuously
Doses / concentrations
Dose / conc.:
1 000 mg/kg bw/day (nominal)
Remarks:
given via the diet
No. of animals per sex per dose:
10 females per group
Control animals:
yes

Examinations

Maternal examinations:
POST-MORTEM EXAMINATIONS: Yes
- Organs examined: Uterus, ovaries, placenta
Ovaries and uterine content:
The ovaries and uterine content was examined after termination
Fetal examinations:
- External examinations: Yes

Results and discussion

Results: maternal animals

General toxicity (maternal animals)

Clinical signs:
no effects observed
Gross pathological findings:
no effects observed

Maternal developmental toxicity

Number of abortions:
no effects observed
Changes in number of pregnant:
no effects observed
Details on maternal toxic effects:
Both macroscopic and microscopic features of the uterus, placenta and ovaries appeared normal.

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day
Basis for effect level:
other: no (adverse) effects observed

Maternal abnormalities

Abnormalities:
no effects observed

Results (fetuses)

Reduction in number of live offspring:
no effects observed
External malformations:
no effects observed
Details on embryotoxic / teratogenic effects:
No abortions or fetal malformations were observed in the animals sacrificed on day 25 of pregnancy. No still-born animals were found in the tretment groups and the newborns were free from malformations.

Effect levels (fetuses)

Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day
Basis for effect level:
other: no (adverse) effects observed

Fetal abnormalities

Abnormalities:
no effects observed

Overall developmental toxicity

Developmental effects observed:
no

Any other information on results incl. tables

No effect was found on the number of pregnancies, the macroscopic and microscopic features of uterus, placenta and ovaries. The number of live births and normal offsprings from the dosed groups was comparable to control, no teratogenic effects were observed.

Applicant's summary and conclusion